EUVIMEDEUVIMED entdecken
Open Access

Real-Time Precision Psychiatry for Schizophrenia: A Microfluidic Genotyping and Super-Learner Platform for Treatment Response Prediction

Ji-Qing Li, Tian Tang, Tian-Gui Yu, Qing Wang, Yan-Hong Feng, Jing Qu, Xi-Feng Hu, Qing-Bo Zhao, Hong-Qian Cao, Fu-Zhong Xue

Schizophrenia Bulletin · 2026

DOI: 10.1093/schbul/sbag044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, 2026. Verfasst von Ji-Qing Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan 250012, China. Hauptthemen laut MEDLINE: Schizophrenia, Antipsychotic Agents, Precision Medicine, Pharmacogenetics. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Shandong Province Key Research and Development Program (Science and Technology Demonstration Project), Shandong Province Natural Science Foundation Youth Branch.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antipsychotic treatment response in schizophrenia shows substantial interindividual variability. While pharmacogenomics (PGx) holds potential for personalized prescribing, current models fall short in integrating multimodal factors and meeting real-time clinical decision-making needs. Hypothesis The precision medicine platform integrating multi-dimensional factors can provide guidance for selecting antipsychotic medications for patients with schizophrenia. Study Design This study employed a retrospective cohort design for model development (2019-2021, N = 735) and external validation (2021-2022, N = 90). We integrated PGx profiles, clinical characteristics, and medication data, selected features via random forest recursive feature elimination (RF-RFE), and built a Super Learner ensemble model (incorporating 5 machine learning algorithms) to predict Positive and Negative Syndrome Scale (PANSS) reduction. For 13 prioritized single-nucleotide polymorphisms (SNPs), we developed a kompetitive allele-specific PCR-based microfluidic chip and validated its accuracy against Sanger sequencing in 24 clinical samples. A clinical decision support (CDS) tool integrating genotyping and predictive analytics was deployed. Study Results The Super Learner model achieved a cross-validated RMSE of 7.08 (R2 = 0.89) and an external validation RMSE of 9.02 (R2 = 0.76). The microfluidic chip showed 100% concordance with Sanger sequencing across all 13 SNPs. The integrated CDS system demonstrated sample-to-report feasibility within 3 h.

Conclusions

Microfluidic genotyping and Super Learner platform enables rapid, real-time prediction of antipsychotic treatment response in schizophrenia, providing a scalable tool for early personalized treatment selection during hospitalization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaAntipsychotic AgentsPrecision MedicinePharmacogeneticsMachine LearningDecision Support Systems, ClinicalHumansPolymorphism, Single NucleotideFemalePredictive Learning ModelsRetrospective StudiesMaleAdultPrediction AlgorithmsTreatment Effect Heterogeneity

Stichwörter der Autor:innen

antipsychotic drugmachine learningprediction modelsingle-nucleotide polymorphisms detection

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
  • Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
  • Healthcare Big Data Research Institute, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
  • Department of Health Inspection and Quarantine, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
  • Shandong Provincial Key Medical and Health Laboratory of Shandong Mental Health Center, Shandong University, Jinan 250012, China.
  • Medical Services Section, Pingyi County Psychiatric Hospital, Linyi 276000, China.

Förderung

  • National Natural Science Foundation of China
  • Shandong Province Key Research and Development Program (Science and Technology Demonstration Project)
  • Shandong Province Natural Science Foundation Youth Branch

Zitieren

APA

Li, J. Q., Tang, T., Yu, T. G., Wang, Q., Feng, Y. H., Qu, J., Hu, X. F., Zhao, Q. B., Cao, H. Q., & Xue, F. Z. (2026). Real-Time Precision Psychiatry for Schizophrenia: A Microfluidic Genotyping and Super-Learner Platform for Treatment Response Prediction. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbag044

Vancouver

Li JQ, Tang T, Yu TG, Wang Q, Feng YH, Qu J, et al. Real-Time Precision Psychiatry for Schizophrenia: A Microfluidic Genotyping and Super-Learner Platform for Treatment Response Prediction. Schizophrenia Bulletin. 2026. doi:10.1093/schbul/sbag044

BibTeX
@article{Li2026,
  author = {Li, Ji-Qing and Tang, Tian and Yu, Tian-Gui and Wang, Qing and Feng, Yan-Hong and Qu, Jing and Hu, Xi-Feng and Zhao, Qing-Bo and Cao, Hong-Qian and Xue, Fu-Zhong},
  title = {Real-Time Precision Psychiatry for Schizophrenia: A Microfluidic Genotyping and Super-Learner Platform for Treatment Response Prediction},
  journal = {Schizophrenia Bulletin},
  year = {2026},
  doi = {10.1093/schbul/sbag044}
}
Kostenlos starten →